作为结核病控制计划的一部分,在山羊身上进行解剖病理学检查的价值,具有阳性比较性皮内结核素测试,作为结核病控制计划的一部分
Jose A Navarro1, Joaquin Sanchez1, Antonio J Buendia1
1Departamento de Anatomía y Anatomía Patológica Comparadas, Facultad de Veterinaria, Universidad de Murcia, Murcia, Spain.
The Veterinary record
|January 24, 2025
概括
尸检证实,山羊结核病 (TB) 检测中的错误阳性是由于结核病或Corynebacterium伪结核病感染,而不是结核病. 这凸显了死后分析在准确诊断山羊结核病方面的价值.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 传染性疾病 传染性疾病
- 动物卫生 动物健康
背景情况:
- 由Mycobacterium bovis和Mycobacterium caprae引起的结核病是使用比较性皮内结核素 (CIT) 试验来管理的.
- 由于感染Corynebacterium伪结核病或Mycobacterium avium亚种结核病 (MAP),CIT测试的特异性可能会受到损害.
- 较低的阳性预测值需要进行死后检查,以准确验证结核病状况.
研究的目的:
- 通过使用CIT测试,调查山羊结核病测试中虚假阳性结果的原因.
- 评估死后检查在确认山羊结核病状况方面的有用性.
主要方法:
- 在2015年至2020年期间,来自14个羊群的37只CIT阳性山羊接受了尸检.
- 在穆尔西亚兽医医学院进行了解剖病理学分析.
主要成果:
- 尸检排除了所有采样山羊的结核病变.
- 在23只山羊中发现了帕拉结核病 (MAP感染),在6只山羊中发现了Corynebacterium伪结核病感染.
- 在参加的群体中,直到2023年,没有观察到正反应器的复发.
结论:
- 解剖病理学检查是一种有效,快速和经济高效的方法,用于确定山羊群的结核病状况.
- 该研究确定了MAP和Corynebacterium伪结核病是山羊中虚假阳性CIT测试结果的常见原因.
更多相关视频
15:57Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
Published on: July 11, 2015
12.2K
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.8K
相关概念视频
Pulmonary Tuberculosis IV
132
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
132
Pulmonary Tuberculosis III
301
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
301
Pulmonary Tuberculosis II
211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
